Online Media Kit
FEATURED STORY
March 16, 2022 | Times LIVE (South Africa)
More HIV prevention options for SA women as vaginal ring approved
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women. More »
FEATURED STORY
February 26, 2022 | The East African (Kenya)
Young women prefer vaginal ring to daily oral pill for HIV prevention
Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring. More »
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »
Media Highlights
February 20, 2020 | Healio / Infectious Disease News
DELIVER trial to test dapivirine ring, PrEP for safety in pregnant women
The NIH announced the start of the first clinical trial designed specifically to test the safety of the monthly dapivirine vaginal ring in pregnant women. More »
February 20, 2020 | Pharmacy Times
First Clinical Trial to Test PrEP, Dapivirine Ring for Safety in Pregnant Women Begins
The study complements an ongoing NIH-funded trial of PrEP in adolescents and young women during pregnancy and the first 6 months after birth. More »
February 17, 2020 | POZ
Trial Will Assess HIV-Preventing Vaginal Ring and PrEP in Pregnant Women
The safety trial will enroll pregnant women in several sub-Saharan African nations. More »
February 17, 2020 | ContagionLIVE
Phase 3 Trial to Assess Dapivirine Ring for Safety in Pregnant Women
The NIH has launched the first clinical trial evaluating the safety of a monthly dapivirine ring among pregnant women in eastern and southern Africa. More »
February 15, 2020 | ContagionLIVE
The ID Pipeline: FDA Activity From the Week of February 9, 2020
A roundup of infectious disease-related FDA news from the week of February 9, 2020 included the launch of the DELIVER trial. More »